Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Express Scripts Boosts Formulary Exclusions With Focus On Multi-Source Brands

Executive Summary

Pharmacy benefit manager adds 64 drugs to its list of formulary exclusions for 2018, bringing to 159 the number designated as not covered.

Advertisement

Related Content

Express Scripts Rewards Low List-Priced Brands In 2019 Formulary, Retains Focus On Rebates
Express Scripts Rewards Low List-Priced Brands In 2019 Formulary, Retains Focus On Rebates
Express Scripts Combination With Cigna's PBM Could Reverse Deficit From Losing Anthem
Large Employers Exploring Value-Based Contracting For Specialty Drugs
Policy Prescriptions: User Fees, EMA Worries, PBM Strategies, PRIME Milestones
CVS 2018 Formulary: Outcomes-Based Contracts In Oncology, Obesity, COPD
Curtain Falls On Opana ER As Endo Agrees To US FDA Withdrawal Request
CVS Expands Formulary Exclusions In 2017, Express Scripts’ Tally Unchanged

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS121229

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel